Frequency and effects of mutations in the KRAS gene on the survival of patients after surgical treatment of intrahepatic cholangiocarcinoma

Aim. To study the effect of mutations in the KRAS gene on the clinical course of intrahepatic cholangiocellular cancer (ICC) after surgical treatment in the Russian population.Materials and methods. A molecular genetic study of tumour tissue samples from 33 patients with intrahepatic cholangiocellul...

Full description

Bibliographic Details
Main Authors: B. N. Gurmikov, D. V. Kalinin, I. G. Nikitin, T. A. Zhinzhilo, A. N. Shipilova, A. V. Chzhao
Format: Article
Language:Russian
Published: Ministry of Healthcare of the Russian Federation. “Kuban State Medical University” 2020-04-01
Series:Кубанский научный медицинский вестник
Subjects:
Online Access:https://ksma.elpub.ru/jour/article/view/2140
_version_ 1826568718136639488
author B. N. Gurmikov
D. V. Kalinin
I. G. Nikitin
T. A. Zhinzhilo
A. N. Shipilova
A. V. Chzhao
author_facet B. N. Gurmikov
D. V. Kalinin
I. G. Nikitin
T. A. Zhinzhilo
A. N. Shipilova
A. V. Chzhao
author_sort B. N. Gurmikov
collection DOAJ
description Aim. To study the effect of mutations in the KRAS gene on the clinical course of intrahepatic cholangiocellular cancer (ICC) after surgical treatment in the Russian population.Materials and methods. A molecular genetic study of tumour tissue samples from 33 patients with intrahepatic cholangiocellular cancer obtained after surgical treatment was carried out using real-time polymerase chain reaction.Results. In the Russian population, the frequency of mutations in the KRAS gene in ICC was 27%, mainly in 12 (78%), 13 (33%), 61 (55%), 117 (44%) and 146 (44%) codons of 2, 3, 4 exons. In terms of KRAS gene mutations, intrahepatic cholangiocellular cancer is characterised by a pronounced heterogeneity. As a rule, the KRAS gene demonstrates multiple mutations at several loci and co-mutations in other genes, in particular, in IDH1/IDH2, PIK3CA, NRAS and BRAF genes. KRAS gene mutations in ICC were found to be significantly more common in women. The overall survival rate was significantly higher in patients with a KRAS mutation as compared to those with the wild type of the gene. Regarding the relapse-free survival rate in the groups of patients with the mutant and wild type of the KRAS gene, no significant differences were found.Conclusion. In the Russian population, no negative association between mutations in the KRAS gene and clinical outcomes was observed.
first_indexed 2024-03-07T21:47:38Z
format Article
id doaj.art-91924d43c5c94a7ba72e5eefd1796c11
institution Directory Open Access Journal
issn 1608-6228
2541-9544
language Russian
last_indexed 2025-03-14T11:27:53Z
publishDate 2020-04-01
publisher Ministry of Healthcare of the Russian Federation. “Kuban State Medical University”
record_format Article
series Кубанский научный медицинский вестник
spelling doaj.art-91924d43c5c94a7ba72e5eefd1796c112025-03-02T10:05:35ZrusMinistry of Healthcare of the Russian Federation. “Kuban State Medical University”Кубанский научный медицинский вестник1608-62282541-95442020-04-01272596910.25207/1608-6228-2020-27-2-59-691174Frequency and effects of mutations in the KRAS gene on the survival of patients after surgical treatment of intrahepatic cholangiocarcinomaB. N. Gurmikov0D. V. Kalinin1I. G. Nikitin2T. A. Zhinzhilo3A. N. Shipilova4A. V. Chzhao5A.V. Vishnevsky National Medical Research Center for SurgeryA.V. Vishnevsky National Medical Research Center for SurgeryNational Medical Research Center Treatment and Rehabilitation CenterNational Medical Research Center Treatment and Rehabilitation CenterA.V. Vishnevsky National Medical Research Center for SurgeryA.V. Vishnevsky National Medical Research Center for SurgeryAim. To study the effect of mutations in the KRAS gene on the clinical course of intrahepatic cholangiocellular cancer (ICC) after surgical treatment in the Russian population.Materials and methods. A molecular genetic study of tumour tissue samples from 33 patients with intrahepatic cholangiocellular cancer obtained after surgical treatment was carried out using real-time polymerase chain reaction.Results. In the Russian population, the frequency of mutations in the KRAS gene in ICC was 27%, mainly in 12 (78%), 13 (33%), 61 (55%), 117 (44%) and 146 (44%) codons of 2, 3, 4 exons. In terms of KRAS gene mutations, intrahepatic cholangiocellular cancer is characterised by a pronounced heterogeneity. As a rule, the KRAS gene demonstrates multiple mutations at several loci and co-mutations in other genes, in particular, in IDH1/IDH2, PIK3CA, NRAS and BRAF genes. KRAS gene mutations in ICC were found to be significantly more common in women. The overall survival rate was significantly higher in patients with a KRAS mutation as compared to those with the wild type of the gene. Regarding the relapse-free survival rate in the groups of patients with the mutant and wild type of the KRAS gene, no significant differences were found.Conclusion. In the Russian population, no negative association between mutations in the KRAS gene and clinical outcomes was observed.https://ksma.elpub.ru/jour/article/view/2140kras gene mutationintrahepatic cholangiocarcinomasurgical treatmentclinical course
spellingShingle B. N. Gurmikov
D. V. Kalinin
I. G. Nikitin
T. A. Zhinzhilo
A. N. Shipilova
A. V. Chzhao
Frequency and effects of mutations in the KRAS gene on the survival of patients after surgical treatment of intrahepatic cholangiocarcinoma
Кубанский научный медицинский вестник
kras gene mutation
intrahepatic cholangiocarcinoma
surgical treatment
clinical course
title Frequency and effects of mutations in the KRAS gene on the survival of patients after surgical treatment of intrahepatic cholangiocarcinoma
title_full Frequency and effects of mutations in the KRAS gene on the survival of patients after surgical treatment of intrahepatic cholangiocarcinoma
title_fullStr Frequency and effects of mutations in the KRAS gene on the survival of patients after surgical treatment of intrahepatic cholangiocarcinoma
title_full_unstemmed Frequency and effects of mutations in the KRAS gene on the survival of patients after surgical treatment of intrahepatic cholangiocarcinoma
title_short Frequency and effects of mutations in the KRAS gene on the survival of patients after surgical treatment of intrahepatic cholangiocarcinoma
title_sort frequency and effects of mutations in the kras gene on the survival of patients after surgical treatment of intrahepatic cholangiocarcinoma
topic kras gene mutation
intrahepatic cholangiocarcinoma
surgical treatment
clinical course
url https://ksma.elpub.ru/jour/article/view/2140
work_keys_str_mv AT bngurmikov frequencyandeffectsofmutationsinthekrasgeneonthesurvivalofpatientsaftersurgicaltreatmentofintrahepaticcholangiocarcinoma
AT dvkalinin frequencyandeffectsofmutationsinthekrasgeneonthesurvivalofpatientsaftersurgicaltreatmentofintrahepaticcholangiocarcinoma
AT ignikitin frequencyandeffectsofmutationsinthekrasgeneonthesurvivalofpatientsaftersurgicaltreatmentofintrahepaticcholangiocarcinoma
AT tazhinzhilo frequencyandeffectsofmutationsinthekrasgeneonthesurvivalofpatientsaftersurgicaltreatmentofintrahepaticcholangiocarcinoma
AT anshipilova frequencyandeffectsofmutationsinthekrasgeneonthesurvivalofpatientsaftersurgicaltreatmentofintrahepaticcholangiocarcinoma
AT avchzhao frequencyandeffectsofmutationsinthekrasgeneonthesurvivalofpatientsaftersurgicaltreatmentofintrahepaticcholangiocarcinoma